Cargando…
The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer
BACKGROUND: Plasma and tissue biopsy have both used for targeting actionable driver gene mutations in lung cancer, whose concordance is imperfect. A reliable method to predict the concordance is urgently needed to ease clinical application. METHODS: A total of 1012 plasma samples, including 519 with...
Autores principales: | Zhao, Chenglong, Li, Jianghua, Zhang, Yongchang, Han, Rui, Wang, Yubo, Li, Li, Zhang, Yimin, Zhu, Mengxiao, Zheng, Jie, Du, Haiwei, Hu, Chen, Zhou, Chengzhi, Yang, Nong, Cai, Shangli, He, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028052/ https://www.ncbi.nlm.nih.gov/pubmed/36341686 http://dx.doi.org/10.1002/cam4.5410 |
Ejemplares similares
-
Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
por: Han, Rui, et al.
Publicado: (2023) -
Power and Promise of Next-Generation Sequencing in Liquid Biopsies
and Cancer Control
por: Wu, Ting-Miao, et al.
Publicado: (2020) -
Next-generation sequencing in liquid biopsy: cancer screening and early detection
por: Chen, Ming, et al.
Publicado: (2019) -
Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis
por: Pang, Bairen, et al.
Publicado: (2020) -
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
por: Mellert, Hestia, et al.
Publicado: (2021)